HBC_Logo2020_RGB.png
Hofseth Biocare ASA: COMPLETED ANNUAL GENERAL MEETING
29 avr. 2022 09h17 HE | Hofseth Biocare ASA
The AGM in Hofseth BioCare ASA was held in Kipervikgata 13, Ålesund today on Friday 29 April 2022.All matters were decided according to the proposals in the notice.Please find the minutes from the AGM...
HBC_Logo2020_RGB.png
Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2022
08 avr. 2022 09h49 HE | Hofseth Biocare ASA
The Annual General Meeting of Hofseth BioCare ASA will be held at the company's premises at Kipervikgata 13, 6003 Ålesund, on 29 April 2022 at 13:00 CET. Please find the notice to the Annual General...
HBC_Logo2020_RGB.png
Hofseth Biocare ASA: HBC ANNUAL REPORT 2021
25 mars 2022 11h48 HE | Hofseth Biocare ASA
Today, 25 March 2022, the Board of Directors of Hofseth BioCare ASA approved the Annual Report for 2021. Please find the Annual Report 2021 and ESG Report attached. For further information, please...
HBC_Logo2020_RGB.png
Hofseth Biocare ASA: HOFSETH BIOCARE AWARDED BEST SUSTAINABLE BIOTECH COMPANY 2022 ACCOLADE
11 mars 2022 02h00 HE | Hofseth Biocare ASA
Hofseth BioCare (HBC) has been named Best Sustainable Biotech Company 2022 in the Global Health & Pharma Biotechnology Awards. The award is in recognition of HBC’s 15 years of pioneering research...
HBC_Logo2020_RGB.png
Hofseth Biocare ASA: HOFSETH BIOCARE SECURES INNOVATION AWARD FOR MEDICAL NUTRITION
08 févr. 2022 02h00 HE | Hofseth Biocare ASA
Hofseth BioCare (HBC) has been named Most Innovative Human Medical Nutrition Ingredients Producer in the ghp Technology Awards announced today. The award recognises the 15 years’ R&D and...
HBC_Logo2020_RGB.png
Hofseth Biocare ASA: FOURTH QUARTER 2021 FINANCIAL REPORT
04 févr. 2022 01h59 HE | Hofseth Biocare ASA
Hofseth BioCare ASA (“HBC”) had gross operating revenues of NOK 26.1m (23.1m) in the fourth quarter and total operating revenues of NOK 87.6m (69.3) for the full year. Cost of sales (CoGS) amounted to...
HBC_Logo2020_RGB.png
Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE
22 déc. 2021 08h34 HE | Hofseth Biocare ASA
Roger Hofseth has today, 22 December 2021, bought 50,000 shares at an average price of approx. NOK 7.332 per share. Roger Hofseth is CEO and primary insider of Hofseth BioCare ASA. After the...
HBC_Logo2020_RGB.png
Hofseth Biocare ASA: COMPLETED EXTRAORDINARY GENERAL MEETING
03 déc. 2021 07h55 HE | Hofseth Biocare ASA
The Extraordinary General Meeting in Hofseth BioCare ASA was held at the premises of the Company in Ålesund, Norway today Friday 3 December 2021. The proposal for supplementary election of Amy...
HBC_Logo2020_RGB.png
Hofseth Biocare ASA: HBC INGREDIENTS SUCCESSFULLY RECEIVE NEW DIETARY INGREDIENT (NDI) STATUS FROM THE US FDA
02 déc. 2021 02h45 HE | Hofseth Biocare ASA
Hofseth Biocare ASA is Now Part of an Exclusive Short-List of Companies to Have Successfully Obtained NDI Status for CalGo® and OmeGo® Nutritional Supplements Extracted from Norwegian Atlantic salmon....
HBC_Logo2020_RGB.png
Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE
18 nov. 2021 08h40 HE | Hofseth Biocare ASA
Roger Hofseth has today, 18 November 2021, bought 55,000 shares at an average price of approx. NOK 7.25 per share. Roger Hofseth is CEO and primary insider of Hofseth BioCare ASA. After the...